血小板减少-话题@MedSci

#血小板减少#

161篇内容 | 5095人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302798, encodeId=fa5b1302e98c6, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, objectType=article, longId=151535, objectId=817b1515353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b1515353f, replyNumber=0, likeNumber=60, createdTime=2018-10-23, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b1515353f, moduleTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817b1515353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302797, encodeId=e8d11302e9777, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少, objectType=article, longId=150825, objectId=7a6715082543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6715082543, replyNumber=0, likeNumber=74, createdTime=2018-10-13, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6715082543, moduleTitle=Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6715082543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302796, encodeId=0bc11302e96e0, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化, objectType=article, longId=150227, objectId=262115022ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=262115022ecf, replyNumber=0, likeNumber=92, createdTime=2018-10-03, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=262115022ecf, moduleTitle=J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=262115022ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302795, encodeId=b3331302e95fe, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率, objectType=article, longId=148679, objectId=fdc51486e958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdc51486e958, replyNumber=0, likeNumber=71, createdTime=2018-09-13, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdc51486e958, moduleTitle=Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdc51486e958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302794, encodeId=56e61302e9473, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=FDA批准Shionogi的Mulpleta治疗慢性肝病引起的血小板减少症, objectType=article, longId=145680, objectId=994d145680d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=994d145680d1, replyNumber=0, likeNumber=70, createdTime=2018-08-03, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=994d145680d1, moduleTitle=FDA批准Shionogi的Mulpleta治疗慢性肝病引起的血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=994d145680d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302793, encodeId=99ba1302e9341, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Lancet infect dis：高热伴血小板减少综合征（SFTS）的流行病学和临床特征, objectType=article, longId=145209, objectId=2a0914520936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a0914520936, replyNumber=0, likeNumber=78, createdTime=2018-07-27, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a0914520936, moduleTitle=Lancet infect dis：高热伴血小板减少综合征（SFTS）的流行病学和临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a0914520936)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302792, encodeId=36511302e9240, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析, objectType=article, longId=142832, objectId=10f014283224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10f014283224, replyNumber=0, likeNumber=134, createdTime=2018-07-11, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10f014283224, moduleTitle=J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10f014283224)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302791, encodeId=2ed91302e9194, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, objectType=article, longId=142211, objectId=ce0814221166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce0814221166, replyNumber=0, likeNumber=57, createdTime=2018-07-04, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce0814221166, moduleTitle=Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce0814221166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302790, encodeId=fcf31302e90fb, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：HIT抗原的动态细胞间交换可调控肝素诱导的血小板减少症, objectType=article, longId=141098, objectId=fef1141098fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef1141098fb, replyNumber=0, likeNumber=51, createdTime=2018-06-21, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef1141098fb, moduleTitle=Blood：HIT抗原的动态细胞间交换可调控肝素诱导的血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef1141098fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302789, encodeId=79151302e890c, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：基因编辑可治疗G6b-B突变导致的先天性巨血小板减少症&局灶性骨髓纤维化, objectType=article, longId=140914, objectId=0494140914ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0494140914ef, replyNumber=0, likeNumber=72, createdTime=2018-06-17, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0494140914ef, moduleTitle=Blood：基因编辑可治疗G6b-B突变导致的先天性巨血小板减少症&局灶性骨髓纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0494140914ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302788, encodeId=e97e1302e88d8, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Mol Ther：上海药物所发现整合素aIIbβ3的种属差异与单抗诱导的血小板减少症相关, objectType=article, longId=139415, objectId=be7d13941541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be7d13941541, replyNumber=0, likeNumber=69, createdTime=2018-05-31, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be7d13941541, moduleTitle=Mol Ther：上海药物所发现整合素aIIbβ3的种属差异与单抗诱导的血小板减少症相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be7d13941541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302787, encodeId=e2c31302e8742, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=FDA批准Doptelet用于血小板减少症的治疗, objectType=article, longId=138880, objectId=fde5138880de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde5138880de, replyNumber=0, likeNumber=78, createdTime=2018-05-24, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde5138880de, moduleTitle=FDA批准Doptelet用于血小板减少症的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde5138880de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302786, encodeId=52f81302e86f2, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Infect Dis：间日疟与恶性疟患者相比较患严重血小板减少症, objectType=article, longId=136498, objectId=9525136498f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9525136498f2, replyNumber=0, likeNumber=57, createdTime=2018-04-27, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9525136498f2, moduleTitle=Infect Dis：间日疟与恶性疟患者相比较患严重血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9525136498f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302785, encodeId=37131302e8565, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=重组人白介素-11治疗血小板减少症临床应用中国专家共识(2018年版), objectType=article, longId=136396, objectId=ba29136396f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba29136396f4, replyNumber=0, likeNumber=24, createdTime=2018-04-26, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba29136396f4, moduleTitle=重组人白介素-11治疗血小板减少症临床应用中国专家共识(2018年版), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba29136396f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302784, encodeId=18341302e8463, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, objectType=article, longId=135793, objectId=34e3135e935e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e3135e935e, replyNumber=0, likeNumber=46, createdTime=2018-04-20, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e3135e935e, moduleTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34e3135e935e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302783, encodeId=cfb11302e831b, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, objectType=article, longId=135517, objectId=1c0113551ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0113551ea6, replyNumber=0, likeNumber=69, createdTime=2018-04-18, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0113551ea6, moduleTitle=Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0113551ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302782, encodeId=2fc61302e8258, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Semin Arthritis Rheu：B细胞消除治疗原发性抗磷脂综合征严重血小板减少的长期疗效, objectType=article, longId=135480, objectId=26901354806d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26901354806d, replyNumber=0, likeNumber=124, createdTime=2018-04-18, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26901354806d, moduleTitle=Semin Arthritis Rheu：B细胞消除治疗原发性抗磷脂综合征严重血小板减少的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26901354806d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302781, encodeId=d9b21302e8123, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Blood：免疫性血小板减少研究新进展, objectType=article, longId=132819, objectId=9788132819f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9788132819f7, replyNumber=0, likeNumber=144, createdTime=2018-03-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9788132819f7, moduleTitle=Blood：免疫性血小板减少研究新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9788132819f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302780, encodeId=6eae1302e809a, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=肝素诱导的血小板减少症中国专家共识（2017）, objectType=article, longId=129157, objectId=34cf12915ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34cf12915ecd, replyNumber=0, likeNumber=32, createdTime=2018-02-09, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34cf12915ecd, moduleTitle=肝素诱导的血小板减少症中国专家共识（2017）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34cf12915ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302779, encodeId=e9f91302e7960, content=<a href='/topic/show?id=9c72890153c' target=_blank style='color:#2F92EE;'>#血小板减少#</a>, objectTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, objectType=article, longId=127999, objectId=036712e999a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036712e999a7, replyNumber=0, likeNumber=36, createdTime=2018-01-29, rootId=0, userName=lingaifan, userId=2e07307, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036712e999a7, moduleTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036712e999a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血小板减少

2020-05-29

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜

2018-10-23

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少

2018-10-13

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化

2018-10-03

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：利妥昔单抗预处理可降低血栓形成性血小板减少性紫癜患者的长期复发率

2018-09-13

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

FDA批准Shionogi的Mulpleta治疗慢性肝病引起的血小板减少症

2018-08-03

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Lancet infect dis：高热伴血小板减少综合征（SFTS）的流行病学和临床特征

2018-07-27

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析

2018-07-11

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：ADAP缺陷可影响巨核细胞极化、促进血小板前体异位释放，从而导致微血小板减少症

2018-07-04

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：HIT抗原的动态细胞间交换可调控肝素诱导的血小板减少症

2018-06-21

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Blood：基因编辑可治疗G6b-B突变导致的先天性巨血小板减少症&局灶性骨髓纤维化

2018-06-17

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Mol Ther：上海药物所发现整合素aIIbβ3的种属差异与单抗诱导的血小板减少症相关

2018-05-31

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

FDA批准Doptelet用于血小板减少症的治疗

2018-05-24

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Infect Dis：间日疟与恶性疟患者相比较患严重血小板减少症

2018-04-27

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

重组人白介素-11治疗血小板减少症临床应用中国专家共识(2018年版)

2018-04-26

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜

2018-04-20

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Circ: Cardiovasc Inte：经皮冠脉介入治疗后获得性血小板减少症的发病率、预测因子和结局

2018-04-18

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Semin Arthritis Rheu：B细胞消除治疗原发性抗磷脂综合征严重血小板减少的长期疗效

2018-04-18

仁者大医 (审核中...)

前往app查看评论内容

#血小板减少#

Blood：免疫性血小板减少研究新进展

2018-03-20

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

肝素诱导的血小板减少症中国专家共识（2017）

2018-02-09

lingaifan (审核中...)

前往app查看评论内容

#血小板减少#

Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪

2018-01-29

科室
- - 订阅+
  - 更多科室
工具
服务